What are Gonadotropin Releasing Hormone Agonists (GnRH)?

Gonadotropin Releasing Hormone Agonists (GnRH)

Injectable medication
Paper Boat Creative/Getty images

Question: What are Gonadotropin Releasing Hormone Agonists (GnRH)?

Answer: Gonadotropin releasing hormone agonists (GnRH) are a type of medication that suppresses ovulation by stopping the production of estrogen and progesterone.

Gonadatropin-Releasing Hormone is a naturally occurring hormone in the body. It is released by the hypothalamus and it controls the release of follicle stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland. These hormones FSH and LH then stimulate the production of estrogen and progesterone in the ovaries. It is this relationship known as the hypothalamic pituitary ovarian axis that controls your menstrual cycle.

In order for this axis to function properly and result in ovulation GnRH has to be released in a pulsatile fashion. If this axis is functioning properly you will have regular periods if you didn’t get pregnant when you ovulated.

The class of medications known as GnRH agonists exploits this need for pulsatile secretion of GnRH. The medication results in a continuous stimulation of the pituitary gland. At first there can be a brief surge of FSH and LH release but then the non pulsatile concentration of GnRH  causes the pituitary gland to stop producing FSH and LH, which ultimately turns off hormone production in the ovary.

The three GnRH agonists commonly used in clinical practice are:

Lupron- leuprolide

Zoladex- goserelin

Synarel- nafarelin

Leuprolide and goserelin are administered by injection in doses for every 4 weeks or 12 weeks while nafarelin is administered by a nasal spray 1-2 times daily. Most women will experience suppression of their ovaries by 4 weeks and almost all women will after 8 weeks of treatment.

Because GnRH agonists temporarily turn off your ovaries production of estrogen and progesterone this class of medications is used to treat certain conditions in women that are estrogen and progesterone dependent. These include:


Uterine Fibroids

Management of heavy menstrual bleeding

Severe Premenstrual syndrome/Premenstrual dysphoria disorder

Infertility treatment

There is also some evidence to suggest that GnRH agonists may also help preserve ovarian functionin women undergoing chemotherapy for breast cancer.

These medications are very effective treatment options. Unfortunately they have some significant side effects. Because they suppress your ovaries production of hormones the side effects of GnRH agonists mimics the symptoms of menopause. These side effects include:

Hot flashes- most common reported in 80% of women

Vaginal dryness

Decreased libido



Mood disturbances

Decreased bone mineral density

Obviously the menopausal symptoms are unpleasant but the most concerning side effect is the loss of bone mineral density. In general the bone loss is reversed after treatment has stopped but in a small amount of women this bone loss may never be fully recovered.

To prevent the loss of bone associated with GnRH treatment your doctor will likely prescribe a progestin or a combination of estrogen and a progestin. This is known as add back therapy and it has been shown to be effective in preventing the bone loss associated with extended use of GnRH agonists. It also may help reduce the severity of the hot flashes as well.

Updated by Andrea Chisholm MD

Was this page helpful?
Article Sources
  • Magnon N.Gonadotropin releasing hormone agonists:Expanding vistas; Indian Journal Endocrinology Metabolism. 2011 Oct-Dec;15(4):261-267